European Society for Medical Oncology guidelines for managing ICI induced psoriasis indicate systemic steroids should be used cautiously due to risk of rebound flare; topical steroids and vitamin D, systemic retinoids, IL-12 and IL-23 inhibitors should be considered first.4 The gene discussed is IL37; the disease is psoriasis.